ABSTRACT
Introduction: Electronic Heath Records (EHRs) play a vital role in facilitating streamlined service provision and governance across the Australian health system. In light of the recent challenges due to the COVID-19 pandemic, an ageing population, health workforce silos and growing inefficiencies in traditional systems, a detailed historical analysis of the use of EHRs research in Australia is timely. The aim of this study is to examine the trends and patterns in EHR research in Australia over the last three decades utilising bibliometrics. Methods: Data for the bibliometric analysis was sourced from Web of Science Core Collection. The search strategy identified articles on EHR research in Australia between 1991 and 2022. Key fields included were author(s), affiliation, year of publication, source, author’s keywords, and citations. R and R Studio was used to conduct the analysis, using bibliometrix library and biblioshiny interface. Results: A total of 951 articles, published in 443 sources were included in the bibliometric analysis. Original research articles made up the vast majority of the publications (n=837; 88.0%). The annual growth rate of EHR research in Australia was about 17.1%. Since 2022, the main trend topics in EHR research were COVID-19, opioid usage, and natural language processing. Thematic analysis indicated aged care, clinical decision support systems, cardiovascular disease, drug allergy and adverse drug reaction as the ‘hot’ themes in EHR research in Australia. Rehabilitation, ambulance/emergency services and monitoring were niche areas of research. Conclusion: The study shows a significant uptrend in EHR related research in Australia. The emerging intellectual and collaborative structure of this inter-disciplinary field provides a reference point for academics involved in this field of research. Data also provides guidance for policy makers and funding institutions in terms of the most significant contributions and key fields of research. The implication of the research could also be interesting for the public information and general knowledge of the community.
Subject(s)
COVID-19 , Drug Hypersensitivity , Cardiovascular DiseasesABSTRACT
Coronary artery disease (CAD) is a major contributor to morbidity and mortality worldwide. Myocardial ischemia may occur in patients with normal or non-obstructive CAD on invasive coronary angiography (ICA). The comprehensive evaluation of coronary CT angiography (CCTA) integrated with fractional flow reserve derived from CCTA (CT-FFR) to CAD may be essential to improve the outcomes of patients with non-obstructive CAD. China CT-FFR Study-2 (ChiCTR2000031410) is a large-scale prospective, observational study in 29 medical centers in China. The primary purpose is to uncover the relationship between the CCTA findings (including CT-FFR) and the outcome of patients with non-obstructive CAD. At least 10,000 patients with non-obstructive CAD but without previous revascularization will be enrolled. A 5-year follow-up will be performed. The primary endpoint is the occurrence of major adverse cardiovascular events (MACE), including all-cause mortality, non-fatal myocardial infarct, unplanned revascularization, and hospitalization for unstable angina. Clinical characteristics, laboratory and imaging examination results will be collected to analyze their prognostic value.